These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 752612)

  • 1. [Animal experiment evaluation of myocardial protection with a magnesium-asparaginate-procaine solution].
    Walpoth B; Fornaro M; von Gossler W; Turina M
    Chir Forum Exp Klin Forsch; 1978; (1978):99-102. PubMed ID: 752612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three methods of myocardial protection.
    Isselhard W; Schorn B; Hügel W; Uekermann U
    Thorac Cardiovasc Surg; 1980 Oct; 28(5):329-36. PubMed ID: 6161431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myocardial metabolic status in various methods of inducing a reversible heart arrest].
    Isselhard W; Schorn B; Uekermann U; Hügel W
    Chir Forum Exp Klin Forsch; 1979; ():29-32. PubMed ID: 456143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial protective effect using membrane stabilization in ischemic heart arrest in hypothermia].
    Fey KH; Follette D; Maloney JV; Buckberg GD
    Chir Forum Exp Klin Forsch; 1978; (1978):103-5. PubMed ID: 752572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of postischemic myocardial dysfunction by substrate repletion during reperfusion.
    Haas GS; DeBoer LW; O'Keefe DD; Bodenhamer RM; Geffin GA; Drop LJ; Teplick RS; Daggett WM
    Circulation; 1984 Sep; 70(3 Pt 2):I65-74. PubMed ID: 6430593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cardioplegic solution buffering in myocardial protection. A biochemical and histopathological assessment.
    del Nido PJ; Wilson GJ; Mickle DA; Bush BG; Rebeyka IM; Klement P; Harding R; Tait GA
    J Thorac Cardiovasc Surg; 1985 May; 89(5):689-99. PubMed ID: 3990319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of the myocardium during ischemic arrest. Dose-response curves for procaine and lignocaine in cardioplegic solutions.
    Hearse DJ; O'Brien K; Braimbridge MV
    J Thorac Cardiovasc Surg; 1981 Jun; 81(6):873-9. PubMed ID: 7230856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
    Yang SS; Hearse DJ
    Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of perfusion volume of the Custodiol solution on the efficiency of cardioplegia in experiment].
    Zhidkov IL; Belianko IE; Sitnichenko NV; Paliulina MV; Laptiĭ AV
    Anesteziol Reanimatol; 2008; (5):42-7. PubMed ID: 19102231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic myocardial protection. Comparison of nonoxygenated crystalloid, oxygenated crystalloid, and oxygenated fluorocarbon cardioplegic solutions.
    Tabayashi K; McKeown PP; Miyamoto M; Luedtke AE; Thomas R; Allen MD; Misbach GA; Ivey TD
    J Thorac Cardiovasc Surg; 1988 Feb; 95(2):239-46. PubMed ID: 3339891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purine-enriched asanguineous cardioplegia retards adenosine triphosphate degradation during ischemia and improves postischemic ventricular function.
    Wyatt DA; Ely SW; Lasley RD; Walsh R; Mainwaring R; Berne RM; Mentzer RM
    J Thorac Cardiovasc Surg; 1989 May; 97(5):771-8. PubMed ID: 2496276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of free radical scavengers in cardioplegic solutions. Improved protection with peroxidase.
    Menasche P; Grousset C; Gauduel Y; Piwnica A
    J Thorac Cardiovasc Surg; 1986 Aug; 92(2):264-71. PubMed ID: 3016415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of Kirsch's solution on myocardial protection].
    Izumi S
    Nihon Kyobu Geka Gakkai Zasshi; 1983 Nov; 31(11):2049-56. PubMed ID: 6672124
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myocardial protection utilizing hypothermia and cardioplegin during surgical correction of congenital heart disease (author's transl)].
    Hoffmeister HE; Seboldt H; Seybold-Epting W; Stunkat R
    Thoraxchir Vask Chir; 1978 Apr; 26(2):98-103. PubMed ID: 653708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of the hypertrophied left ventricle to global ischemia. Comparison of hyperkalemic cardioplegic solution with and without verapamil.
    Huddleston CB; Wareing TH; Boucek RJ; Hammon JW
    J Thorac Cardiovasc Surg; 1992 May; 103(5):919-26. PubMed ID: 1533256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced ischemic cardiac arrest. Clinical and experimental results with magnesium-aspartate-procaine solution (Cardioplegin).
    Kalmár P; Bleese N; Döring V; Gercken G; Kirsch U; Lierse W; Pokar H; Polonius MJ; Rodewald G
    J Cardiovasc Surg (Torino); 1975; 16(5):470-5. PubMed ID: 1194331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial protection in coronary occlusion by retrograde cardioplegic perfusion via the coronary sinus in dogs. Preservation of high-energy phosphates and regional function.
    Masuda M; Yonenaga K; Shiki K; Morita S; Kohno H; Tokunaga K
    J Thorac Cardiovasc Surg; 1986 Aug; 92(2):255-63. PubMed ID: 3736083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioplegic solutions for myocardial preservation: analysis of hypothermic arrest, potassium arrest, and procaine arrest.
    Harlan BJ; Ross D; Macmanus Q; Knight R; Luber J; Starr A
    Circulation; 1978 Sep; 58(3 Pt 2):I114-8. PubMed ID: 14740690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of Cardioplegin in surgery with extracorporeal circulation].
    Lorkiewicz Z; Borzycka B; Ponizyński A; Blotna-Filipiak M
    Kardiol Pol; 1973; 16(4):299-307. PubMed ID: 4756964
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts.
    Myers CL; Weiss SJ; Kirsh MM; Shepard BM; Shlafer M
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):281-9. PubMed ID: 3945095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.